Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists
Publication type: Journal Article
Publication date: 2021-03-10
scimago Q1
wos Q1
SJR: 0.870
CiteScore: 8.9
Impact factor: 3.9
ISSN: 1061186X, 10292330, 10267158
PubMed ID:
33620269
Pharmaceutical Science
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
International Journal of Pharmaceutics
2 publications, 13.33%
|
|
|
Nutrients
1 publication, 6.67%
|
|
|
Ionics
1 publication, 6.67%
|
|
|
Journal of Drug Delivery Science and Technology
1 publication, 6.67%
|
|
|
Journal of Molecular Liquids
1 publication, 6.67%
|
|
|
Journal of Functional Biomaterials
1 publication, 6.67%
|
|
|
Journal of Drug Targeting
1 publication, 6.67%
|
|
|
Current Pharmaceutical Biotechnology
1 publication, 6.67%
|
|
|
Current Drug Delivery
1 publication, 6.67%
|
|
|
Russian Chemical Reviews
1 publication, 6.67%
|
|
|
Advanced Science
1 publication, 6.67%
|
|
|
Pharmaceutics
1 publication, 6.67%
|
|
|
Frontiers in Immunology
1 publication, 6.67%
|
|
|
RSC Advances
1 publication, 6.67%
|
|
|
1
2
|
Publishers
|
1
2
3
4
|
|
|
Elsevier
4 publications, 26.67%
|
|
|
MDPI
3 publications, 20%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 13.33%
|
|
|
Springer Nature
1 publication, 6.67%
|
|
|
Taylor & Francis
1 publication, 6.67%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 6.67%
|
|
|
Wiley
1 publication, 6.67%
|
|
|
Frontiers Media S.A.
1 publication, 6.67%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 6.67%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
15
Total citations:
15
Citations from 2024:
7
(46.66%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Poudwal S., Misra A., Shende P. Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists // Journal of Drug Targeting. 2021. Vol. 29. No. 8. pp. 834-847.
GOST all authors (up to 50)
Copy
Poudwal S., Misra A., Shende P. Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists // Journal of Drug Targeting. 2021. Vol. 29. No. 8. pp. 834-847.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/1061186x.2021.1894434
UR - https://doi.org/10.1080/1061186x.2021.1894434
TI - Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists
T2 - Journal of Drug Targeting
AU - Poudwal, Swapna
AU - Misra, Ambikanandan
AU - Shende, Pravin
PY - 2021
DA - 2021/03/10
PB - Taylor & Francis
SP - 834-847
IS - 8
VL - 29
PMID - 33620269
SN - 1061-186X
SN - 1029-2330
SN - 1026-7158
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Poudwal,
author = {Swapna Poudwal and Ambikanandan Misra and Pravin Shende},
title = {Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists},
journal = {Journal of Drug Targeting},
year = {2021},
volume = {29},
publisher = {Taylor & Francis},
month = {mar},
url = {https://doi.org/10.1080/1061186x.2021.1894434},
number = {8},
pages = {834--847},
doi = {10.1080/1061186x.2021.1894434}
}
Cite this
MLA
Copy
Poudwal, Swapna, et al. “Role of lipid nanocarriers for enhancing oral absorption and bioavailability of insulin and GLP-1 receptor agonists.” Journal of Drug Targeting, vol. 29, no. 8, Mar. 2021, pp. 834-847. https://doi.org/10.1080/1061186x.2021.1894434.